After five months, all the acne disappeared
however, several mechanisms have been proposed
Twelve hours after doxorubicin administration, animals assigned to receive GHRP-6 were treated with the peptide at a dosage of 3.75 mg/kg body weight, given intraperitoneally every 12 hours for four consecutive days
Safety and Professional Considerations Always: Use sterile cartridges Avoid active infections Avoid if pregnant or medically contraindicated Perform patch test Use SPF daily If unsure, consult a licensed professional
10.1186/s13098-022-00924-8 Summary Keywords GLP-1 receptor agonists, DPP-4 inhibitors, FAERS, adverse events, biliary disorders, pharmacovigilance Citation He L, Li J, Cheng X, Luo L and Huang Y (2025) Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis